• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Italy Porcine Vaccines Market

    ID: MRFR/Pharma/48723-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Italy Porcine Vaccines Market Research Report By Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), By Disease Indication (PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD), Others) and By End-user (Veterinary Hospitals, Hog Production Farm)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Italy Porcine Vaccines Market Infographic
    Purchase Options

    Italy Porcine Vaccines Market Summary

    The Italy Porcine Vaccines market is projected to grow significantly from 57.6 million USD in 2024 to 173.8 million USD by 2035.

    Key Market Trends & Highlights

    Italy Porcine Vaccines Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 10.56% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 173.8 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 57.6 million USD, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced vaccination technologies due to increasing awareness of animal health is a major market driver.

    Market Size & Forecast

    2024 Market Size 57.6 (USD Million)
    2035 Market Size 173.8 (USD Million)
    CAGR (2025-2035) 10.56%

    Major Players

    Hipra, Woods Animal Nutrition, Virbac, Ceva Santé Animale, Heska Corporation, Zoetis, Vetoquinol, IDT Biologika, Merck Animal Health, Bacterial Vaccines, TAP Biosystems, Boehringer Ingelheim, Eli Lilly and Company

    Italy Porcine Vaccines Market Trends

    The Italy Porcine Vaccines Market is observing distinct trends that capture the dire changes within animal healthcare. A primary focus is improving sanitary safety and animal welfare, which is crucial to disease diagnosis and treatment in Italy’s meat industry. The Italian government supports initiatives aimed at improving disease control for livestock, subsequently boosting demand for swine disease vaccines. Also, there is a growing concern among producers regarding the economic advantages of maintaining swine porcine preventive measures, which further increases the demand for porcine vaccines across many farms.

    Recent developments suggest a trend towards more effective multi-target breach vaccines for domestic swine livestock. This innovation is important considering the heterogeneous agricultural profile of Italy and the region-specific disease challenges. Enhancing R&D for effective vaccines will become a critical opportunity within the industry. Farmers looking to improve productivity and overall animal health tend to rely on innovative solutions from veterinary pharmaceutical companies and agriculture organizations that focus on regional issues.

    Also, in keeping with the new technology, digital tools are being used to track and manage swine health, including smart vaccination strategies that decrease disease exposure. The adoption of precision livestock farming opens up the added possibility for targeted individual vaccinations based on the specific health requirements of the herd, thus advancing the porcine vaccine market in Italy. All in all, the innovative approaches towards vaccine development, accompanied by government support and animal welfare policies, are the defining and prospective sustained growth factors of the Italian porcine vaccine industry.

    Market Segment Insights

    Italy Porcine Vaccines Market Segment Insights

    Italy Porcine Vaccines Market Segment Insights

    Porcine Vaccines Market Type Insights

    Porcine Vaccines Market Type Insights

    The Italy Porcine Vaccines Market is characterized by a diverse range of vaccine types that cater to the protection and health management of swine, crucial for both the livestock industry and public health. This market segmentation includes Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, and DNA vaccines, each playing a vital role in immunization strategies against various pathogens affecting pigs. Inactivated vaccines are widely used due to their ability to provoke a strong immune response while ensuring safety, making them a preferred choice among pig farmers for routine vaccination schedules. 

    Live attenuated vaccines garner attention for their effectiveness in stimulating long-lasting immunity; they mimic natural infections and often require fewer doses, enhancing their adoption rate within Italy’s veterinary practices. Toxoid vaccines also hold significance as they protect against toxins produced by certain bacterial infections, aligning well with the stringent animal health regulations in Italy. Recombinant vaccines are noted for their innovation, leveraging genetic engineering to produce antigens that enhance immunity while minimizing risks associated with traditional vaccine production. 

    Conjugate vaccines are gaining traction as they are designed to improve immune responses against polysaccharide antigens, particularly for young animals that are more susceptible to infections. Furthermore, DNA vaccines represent a cutting-edge approach in the landscape of veterinary immunology, utilizing plasmid DNA to evoke a robust immune response, which is increasingly viewed as the future of vaccination in swine. Several growth factors, such as the rising importance of biosecurity measures, the increasing demand for pork, and the growing awareness of disease management among swine producers in Italy, drive the diverse types of vaccines available in this market segment. 

    The evolving landscape of pig farming, influenced by advancements in veterinary research, regulatory changes, and consumer preferences, continues to create opportunities for innovation and adaptation within the Italy Porcine Vaccines Market. Overall, the different types of vaccines play crucial roles in improving animal health productivity and ultimately contributing to the overall economic stability of Italy's livestock sector.

    Porcine Vaccines Market Disease Indication Insights

    Porcine Vaccines Market Disease Indication Insights

    The Disease Indication segment of the Italy Porcine Vaccines Market plays a crucial role in ensuring the health and productivity of swine populations. This market encompasses a variety of diseases, including Porcine Epidemic Diarrhea (PED), Porcine Reproductive and Respiratory Syndrome (PRRS), Swine influenza, Aujeszky's disease, and Porcine Circovirus Associated Disease (PCVAD), among others. PED has gained significant attention in recent years due to its rapid spread and severe impact on piglet mortality, prompting efforts to enhance vaccine development and usage.PRRS continues to be a leading cause of economic losses in swine production, making effective vaccination essential for herd immunity. 

    Swine influenza outbreaks can lead to serious health complications in pigs, thus necessitating timely vaccination to protect livestock. Aujeszky's disease, although controlled in Italy, still poses challenges due to sporadic outbreaks, highlighting the need for ongoing vaccination strategies. PCVAD is linked to various health issues in pigs and remains a priority for health interventions. Collectively, these conditions underscore the importance of the Italy Porcine Vaccines Market in safeguarding the swine industry and promoting overall animal health.

    Porcine Vaccines Market End-user Insights

    Porcine Vaccines Market End-user Insights

    The Italy Porcine Vaccines Market demonstrates a significant division within its End-user segment, particularly in the domains of Veterinary Hospitals and Hog Production Farms. Veterinary Hospitals play a crucial role in the administration of vaccines, focusing on the health management of pigs through preventive care. They not only ensure the well-being of animals but also facilitate effective vaccine distribution, thereby contributing to market growth. On the other hand, Hog Production Farms represent a vital component of the market, as they require reliable vaccination programs to maintain herd health and productivity.

    The increasing demand for high-quality pork products in Italy drives the need for effective vaccination strategies within these farms. Additionally, the government emphasizes livestock health and disease control, which further bolsters the significance of this segment. Overall, both Veterinary Hospitals and Hog Production Farms carry substantial importance in the Italy Porcine Vaccines Market, influencing key aspects such as vaccination efforts, market trends, and responses to health challenges in the swine industry.

    Get more detailed insights about Italy Porcine Vaccines Market

    Key Players and Competitive Insights

    The Italy Porcine Vaccines Market is a dynamic sector characterized by a variety of players striving to meet the demands of a growing livestock industry. The competitive landscape is shaped by the need for effective disease management in swine, as biosecurity concerns and the rising prevalence of infectious diseases impact pig farming practices across the country. Companies within this market are increasingly focusing on research and development to innovate vaccines that enhance the health and productivity of pigs. Strategic alliances, partnerships, and mergers are prevalent as firms seek to bolster their portfolios and expand their market presence. 

    The regulatory environment in Italy further influences competitive strategies as firms navigate compliance with stringent health and safety standards. The market is expected to witness significant growth, underpinned by the increasing awareness of animal welfare and the need for sustainable farming practices.Hipra holds a prominent position in the Italy Porcine Vaccines Market, known for its strong commitment to innovation and quality. The company has developed a robust range of vaccines tailored specifically for swine, targeting key diseases that affect pig health and productivity.

    Hipra’s ability to provide customized solutions and its focus on research and development are pivotal strengths that have solidified its reputation among Italian farmers and veterinarians. 

    The company leverages its extensive experience and utilizes advanced technologies in vaccine development, giving it a competitive edge. The presence of Hipra in Italy is underscored by its dedication to training and education, ensuring that livestock producers are equipped with the latest knowledge and best practices related to porcine health management.Woods Animal Nutrition is another key player in the Italy Porcine Vaccines Market, recognized for its comprehensive approach towards the nutritional needs of pig farming alongside vaccination solutions. The company provides a range of products that support overall animal health, which is crucial in preventing diseases.

    Woods Animal Nutrition has established a solid presence in the Italian market through strategic partnerships and collaborations that enhance its service offerings. 

    The company emphasizes the importance of integrated livestock health management, which strengthens its position within the industry. In addition to vaccines, it offers nutritional supplements that complement vaccination efforts, thus promoting overall herd well-being. Recent mergers and acquisitions have further enhanced Woods Animal Nutrition’s capabilities, allowing it to tap into new technologies and expand its reach within Italy, ultimately contributing to the health and productivity of the nation’s swine industry.

    Key Companies in the Italy Porcine Vaccines Market market include

    Industry Developments

    The Italy Porcine Vaccines Market has seen significant developments recently, particularly in relation to advancements in vaccine technologies and increased demand for efficient disease management among swine populations. Companies such as Zoetis, Ceva Santé Animale, and Boehringer Ingelheim are actively investing in Research and Development to improve vaccine efficacy, with new formulations being introduced to combat diseases like Porcine Reproductive and Respiratory Syndrome (PRRS) and Porcine Epidemic Diarrhea Virus (PEDV). In August 2023, Merck Animal Health announced an expansion in its vaccine production capacity in Italy, aligning with growing market needs. 

    Furthermore, Hipra has focused on bolstering its position in the market, promoting its novel vaccines which have received positive feedback from veterinary professionals. No recent mergers or acquisitions have been publicly reported among key companies like Virbac and Heska Corporation in 2023, indicating a stable competitive landscape. The Italian government continues to support the livestock sector, enhancing regulatory frameworks that aim to promote animal health and welfare, further impacting the dynamics of the Porcine Vaccines Market positively. This market is projected to witness continued growth due to rising pork consumption and the necessity for effective vaccination strategies.

    Market Segmentation

    Outlook

    • Veterinary Hospitals
    • Hog Production Farm

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 53.7(USD Million)
    MARKET SIZE 2024 57.6(USD Million)
    MARKET SIZE 2035 173.8(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 10.561% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Hipra, Woods Animal Nutrition, Virbac, Ceva Santé Animale, Heska Corporation, Zoetis, Vetoquinol, IDT Biologika, Merck Animal Health, Bacterial Vaccines, TAP Biosystems, Boehringer Ingelheim, Eli Lilly and Company
    SEGMENTS COVERED Type, Disease Indication, End-user
    KEY MARKET OPPORTUNITIES Increasing demand for disease control, Growth in pork consumption, Advancements in vaccine technology, Government support for livestock health, Rising awareness of animal welfare
    KEY MARKET DYNAMICS rising disease outbreaks, increasing production efficiency, regulatory pressures, demand for biosecurity measures, technological advancements in vaccination
    COUNTRIES COVERED Italy

    FAQs

    What is the expected market size of the Italy Porcine Vaccines Market in 2024?

    The Italy Porcine Vaccines Market is expected to be valued at 57.6 million USD in 2024.

    How much is the Italy Porcine Vaccines Market projected to grow by 2035?

    By 2035, the market is projected to grow to 173.8 million USD.

    What is the expected compound annual growth rate (CAGR) for the Italy Porcine Vaccines Market from 2025 to 2035?

    The expected CAGR for the Italy Porcine Vaccines Market from 2025 to 2035 is 10.561%.

    Which type of vaccine is expected to dominate the Italy Porcine Vaccines Market by 2035?

    Inactivated vaccines are expected to dominate the market, projected at 63.0 million USD by 2035.

    What is the projected market size for live attenuated vaccines in Italy by 2035?

    The market size for live attenuated vaccines in Italy is projected to be 45.0 million USD by 2035.

    Who are the key players in the Italy Porcine Vaccines Market?

    Key players in the market include Hipra, Woods Animal Nutrition, Virbac, and Zoetis, among others.

    What challenges does the Italy Porcine Vaccines Market currently face?

    The market faces challenges such as regulatory changes and competition among established players.

    What opportunities exist in the Italy Porcine Vaccines Market?

    Opportunities include the development of new vaccine technologies and increasing demand for porcine health products.

    What is the market size for toxoid vaccines in Italy for 2024?

    The market for toxoid vaccines in Italy is valued at 8.0 million USD in 2024.

    How is the growth rate of the Italy Porcine Vaccines Market expected to vary by segment?

    Growth rates are expected to differ among segments, with inactivated vaccines leading the growth through 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials